YONG LI to Treatment Outcome
This is a "connection" page, showing publications YONG LI has written about Treatment Outcome.
Connection Strength
0.066
-
Mutant p53 as an Antigen in Cancer Immunotherapy. Int J Mol Sci. 2020 Jun 08; 21(11).
Score: 0.053
-
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. J Immunother Cancer. 2019 10 22; 7(1):272.
Score: 0.013